Alliance Healthcare UK team members Nick Atkins, Swansea Service Centre Manager, and Karl Goodall, Swansea Driver Team Manager, have climbed Pen y Fan in
South Wales to support the Alzheimer's Society and raise money for dementia. The pair raised over £1,500, a cause close to Nick's heart, as his mother is a
dementia patient.
Dementia mainly affects people aged 65 and over, with 65 per cent of the 944,000 individuals living with dementia in the UK being women. Nick and Karl, dressed
as 'glamorous grannies' with wigs, tights, and dresses, completed the mountain trek in six hours, carrying an Alliance Healthcare medicines cool box weighing over
35 kg.
Alzheimer's Society supports people with dementia and their carers through national care and research efforts. Alzheimer's Society Cymru is the sole UK dementia
charity funding both biomedical and care research.
Centre for Pharmacy PostGraduate Education (CPPE) has announced the launch of a new learning programme, Preparing to train as an independent prescriber.
The programme aims to build the confidence and competence of pharmacists who are planning to apply and train as independent prescribers and is open to pharmacists
from all sectors of practice, including community pharmacists who are planning to commence their independent prescriber training with a Higher Education Institute
(HEI).
The course is made up of four main components, including a self-directed e-course and self-assessment framework, a mandatory online workshop to support you to review
your self-assessment of competencies, an optional online workshop to support your readiness for academic writing and reflective practice, and optional peer support
sessions, providing the opportunity for you to develop your professional network and establish communities of practice.
The Pharmacists' Defence Association (PDA) has begun conciliation with 86 pharmacy companies to safeguard the interests of former LloydsPharmacy pharmacists.
The Advisory, Conciliation and Arbitration Service (Acas), a government agency, serves as a mediator between companies and employees to resolve disputes. If the
ongoing mediation prove unsuccessful, individual employees retain the option to file claims in the employment tribunal, the PDA has said.
The ongoing dispute centres around employers potentially failing to conduct the required consultation under the Transfer of Undertakings (Protection of Employment)
regulations (TUPE) with employees and their representatives during employee transfers, the PDA said.
The TUPE legislation, known for its complexity and technical nature, applies when a section of the company, like a pharmacy sold as an asset using standard disposal,
undergoes a transfer.
According to NHS England's recent pharmaceutical list, LloydsPharmacy has either sold or shuttered 461 branches since September 2022. According to NHSE data, as of
June 30, the pharmacy chain operates approximately 512 pharmacies in England. This positions it as the third-largest chain after Boots UK and Well Pharmacy.
The Centre for Pharmacy Post-Graduate Education (CPPE) has launched Menopause - an introduction for pharmacy professionals e-learning programme.
The new Menopause: an introduction for pharmacy professionals e-learning programme aims to support pharmacist's to increase their knowledge and awareness of
menopause and perimenopause, helping them to have initial conversations with those who need support.
The programme teaches how to equip people experiencing menopausal symptoms with evidence-based information that allows them to make decisions about their own
health management.
This e-learning programme considers a range of topics, including the signs and symptoms associated with menopause and perimenopause, how a diagnosis is made
and the national context supporting a growing role for pharmacy professionals in menopause care.
It also discusses the benefits and risks of treatment options available, the common misconceptions that people may have about menopause and how to apply the
evidence base to practice in order to help support decision making.
Balmedie Pharmacy based in Aberdeenshire, Scotland has been purchased by local expanding multiple operator JMF Healthcare.
Balmedie Pharmacy is a well-performing community pharmacy that dispenses an average of 5,255 items per month. It lies completely unopposed in the large Aberdeenshire
village of Balmedie, which is circa eight miles north of Aberdeen City Centre.
The pharmacy has been owned by Brian Arris since 2004 and was recently brought to market to allow him to pursue other pharmacy business opportunities.
Following a confidential sales process with Christie & Co, JMF Healthcare to benefit from new housing developments in this area of Aberdeenshire such as 300 new
homes planned in Balmedie, approved plans for up to 500 new homes in Trump Menie Estate, and 284 new homes planned in Blackdog Village.
Brian Arris, previous owner of Balmedie Pharmacy, comments, "I'm sad to see the business go as the excellent staff have helped grow the pharmacy from scratch since
2004 and we've all put our hearts and souls into providing good pharmaceutical care for the village and surrounding area. I'm confident everyone is left in safe
hands with John at the helm now."
Pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic services, said the Royal
Pharmaceutical Society (RPS).
RPS's statement has been developed in collaboration with pharmacy organisations who have co-badged the report, such as the British Oncology Pharmacy Association,
the UK Clinical Pharmacy Association, Association of Pharmacy Technicians and the College of Mental Health Pharmacy.
It looks at current and future roles for pharmacy professionals in genomic medicine across many aspects of practice such as person-centred care and collaboration,
professional practice, education, leadership, management and research.
Pharmacists and pharmacy technicians in the UK have already established roles in the application of genomic medicine in some areas of practice, such as antimicrobial
stewardship and infectious diseases, and the management of certain genetic conditions, such as cystic fibrosis.
The society believes, the current role of pharmacy professionals in genomics can be expanded upon in the future to both lead and support many relevant aspects of
genomic implementation. These are described across all healthcare sectors, within the Genome UK strategy produced by the UK Government, and within the implementation
plans published in England, Scotland and Wales.
Lead for Pharmacogenomics at RPS Sophie Harding said: "Pharmacy professionals are the gatekeepers of medication safety and efficacy across all areas of healthcare.
They are skilled at interpreting complex scientific data and use evidence-based medicine to maximise the benefits of treatments for patients, whilst supporting
shared decision-making with patients and the multidisciplinary team.
Blackthorn Pharmacy in Southampton, Hampshire has been sold to expanding operator, Rosechem Limited, which has multiple other pharmacies in Hampshire and
Surrey for an undisclosed amount.
This health centre pharmacy dispenses an impressive average of 25,000 items per month. It has been owned by Patrick Stephens for over 25 years and was recently
brought to market to allow him to retire.
Patrick Stephens, previous owner of Blackthorn Pharmacy, commented: "Over the years, with a lot of hard work and support of my pharmacy team, the business had grown
significantly and, after 25 years, I was keen to retire and for someone to take over my business. I am sure the buyer will be successful and will continue to grow
the business and build on the great relationships we have created. I would like to thank Jonathan at Christie & Co for all his hard work and am delighted that the
sale has now completed."
The pharmacy inquiry will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy
services.
It will also consider current challenges around funding, workforce and the digital infrastructure.
Planned developments within the profession will enable future pharmacists to be independent prescribers from day one of registration, giving them a greater role
within primary care teams.
Health and Social Care Committee Chair Steve Brine MP said: "It is clear that pharmacy has a central role to play in the future of the NHS. With a greater focus on
personalised and patient-centred healthcare, we will be asking what more must be done to make sure that the profession is in the best shape to meet demand.
"Better use of the pharmacy workforce would reduce pressures on general practice and hospitals. However, this will not happen without a planned workforce with the
funding, supervision and training to support it.
"At the end of the inquiry, the committee will be making recommendations to the government on what action needs to be taken to ensure the potential of pharmacy is
realised.
A Company Chemists' Association (CCA) analysis has shown that 'Pharmacy First' service in England could free up 30m+ GP appointments each year.
It has urged the Government and NHS to be even 'bolder in their ambition and go further and faster'.
The recent 'Delivery plan for recovering access to primary care' announced a 'Pharmacy First' service for England, mirroring similar approaches in Scotland and
Wales.
The association has estimated that with the added capability to supply non-prescription medicines and prescribe additional prescription-only medicines, an ambitious
'Pharmacy First' service could free up 30m+ GP appointments annually.
Harnessing community pharmacies to deliver care for minor health conditions will effectively create 11,000 urgent care centres in England.
The wholesale supplier and distributor, Alliance Healthcare has successfully raised over £100k for three charities following a series of events in the last
three months.
The healthcare company hosted a Sports Championship event in October to raise funds for Action Medical Research, Vitamin Angels UK, and the Theodora Children's
Charity.
The following competition saw colleagues competing against each other in various football and netball tournaments.
Last month, two teams of seven members participated in a thrilling 2023 Tour D'Alliance cycle challenge to pedal and cover over 300 miles from Great Yarmouth
to Swansea Service Centre.
Pharmacist Support, a charity centred on bolstering pharmacist well-being, has launched the 'ACTNow' campaign 2023, aimed at promoting and supporting the
health and overall wellbeing of pharmacists. This campaign is launched following the successful 2022 initiative, which heightened awareness about wellbeing in
the pharmacy profession.
Launched in May 2020 in response to COVID-19 challenges, ACTNow has transformed into a dynamic platform fostering positive workplace culture, teamwork, and
individual well-being, Pharmacist Support has said. Its primary goals are to inspire individuals and teams in the profession to prioritise their well-being,
support colleagues, and proactively foster a healthier work environment.
Pharmacist Support emphasised that the 2023 ACTNow campaign will continue to prioritise fostering a positive workplace culture. "This year, the campaign will
provide individuals, pharmacy teams, and employers with essential tools, resources, and strategies to effectively support colleagues dealing with distress,
all while cultivating a growth-oriented mindset within their teams," the charity firm said.
Growing up with a family that worked in pharmacy, our dinner time conversation was not like that of other families. Ours would centre around medicines,
prescriptions, and the health challenges within our local community.
I quickly came to understand the importance of the role played by community pharmacists. So I can't help but be concerned that the current direction being taken by
digital health innovation threatens to leave community pharmacies behind.
Whilst it is brilliant that patients can easily access their prescriptions through the rise of online pharmacies, many of these cut out the vital knowledge and
expertise of local community pharmacists, and threaten to end the traditional close ties between local community pharmacists and their patients.
Nine out of 10 NHS users believe that pharmacists play an unrivalled role when it comes to keeping patients in the community safe. We must ensure that digital health
does not replace this important source of advice for health problems and injuries, but instead preserves and enhances this vital, personal role and enables
pharmacists to continue delivering care in new and effective ways.
A vital connection with patients
Community pharmacies provide crucial support to local patients with managing their medicines safely, particularly older and more vulnerable people. The specific
expertise and knowledge held by pharmacists can help inform the long-term management of a patient's condition and ensure they are kept safe from potential side
effects and complications.
Lo's Pharmacy, a Yorkshire-based pharmacy chain is adopting a new approach to hub and spoke in a first of a kind model to be used in the UK.
The pharmacy will centralise its repeat prescription dispensing service for original packs with the support of its medication wholesaler.
The independent group, which has 25 NHS community pharmacies across Yorkshire, will install Centred Solution's Automated FLOWRx Hub product at its central dispensing
facility in Wath-Upon-Dearne, South Yorkshire.
But unlike other FLOWRx customers, who pick packs from a robotic dispensing system or internal warehouse, Lo's Pharmacy will receive patient-specific flow totes
directly from their wholesaler which can then be processed by their hub.
This workflow has not been used anywhere else in the country until now and it is a revolutionary approach to hub and spoke dispensing, showing what can be achieved
when key players decide to collaborate. It further demonstrates that there are range of variations of hub and spoke models available and accessible to independent
and multiple community pharmacies across the UK.
The Royal Pharmaceutical Society (RPS) has appointed Laura Wilson as Director for Scotland commencing 23rd January 2023.
Laura, is currently Policy and Practice Lead for RPS in Scotland. She is accountable for bringing national RPS policy to life for members in Scotland, while
contributing to the GB wide professional leadership agenda.
She will work closely with the Scottish Pharmacy Board, senior NHS officials and other key stakeholders across the breadth of the pharmacy profession and beyond
to ensure pharmacy is on the forefront of healthcare in Scotland.
She joins the existing team of RPS Country Directors, which includes Elen Jones, Director for Wales and James Davies, Director for England and will report directly
to the Chief Executive.
Laura Wilson said: "I am delighted to be appointed Director for Scotland having worked as part of the RPS Scotland team as the policy and practice lead. It will
be an honour to continue the fantastic work started by former Director Clare Morrison to bring Pharmacy 2030, our vision for pharmacy in Scotland in the future,
to life and supporting pharmacy teams to deliver person centred care.
Pharmaceutical giant Bristol Myers Squibb has become the first pharmaceutical company in the UK to be accredited as a 'menopause friendly workplace'.
The accreditation, awarded by an independent panel of judges, recognises employers who put diversity, inclusion and wellbeing at the centre stage of their business.
Bristol Myers Squibb (BMS) said it rung in the changes in recognition of the fact that nearly eight of 10 menopausal women are in work and that this is the fastest
growing demographic in the workforce.
Panel members described BMS UK&I's application as "outstanding" and acknowledged "the huge strides they have made to help normalise the menopause" by fostering an
inclusive culture.
A University College London team of researchers has developed an artificial intelligence (AI) programme that can identify minute brain anomalies that lead to
epileptic seizures.
The algorithm, used in the Multicentre Epilepsy Lesion Detection project (MELD) and which reports locations of abnormalities in cases of drug-resistant focal
cortical dysplasia (FCD) - a major cause of epilepsy - was developed by a multinational team who used more than 1,000 patient MRI scans from 22 international
epilepsy centres.
Brain regions known as FCDs have evolved improperly and frequently lead to drug-resistant epilepsy. Surgery is usually used to treat it, however, finding the
lesions on an MRI is a constant problem for doctors because MRI scans for FCDs can appear normal.
The scientists employed about 300,000 places throughout the brain to quantify cortical properties from the MRI scans, such as how thick or folded the cortex/brain
surface was.
The Royal Pharmaceutical Society (RPS) has published its new 'Core Advanced Pharmacist Curriculum' to enable professional development towards advanced pharmacist
practice.
This follows an intensive programme of work undertaken in collaboration with a wide range of UK stakeholders, the society said today (June 27) in a statement.
The Curriculum will equip pharmacists with advanced leadership, education, and research capabilities which are essential to support, lead and advance the profession
through transformative change so it continues to meet evolving patient and service requirements.
The RPS Core Advanced Curriculum provides the blueprint to develop such individuals by articulating a UK entry-level standard to advanced pharmacist practice,
relevant to all patient-focussed pharmacist roles and aligned to multi-professional definitions of advanced practice.
This curriculum completes the core RPS post-registration curricula, creating a seamless post-registration professional development continuum modelled around five
common domains- Person-centred care and collaboration; Professional practice; Leadership and management; Education; and Research.
Community pharmacists are readily accessible healthcare providers and medicine experts in the community setting and their counsel is often sought by patients
and consumers on a number of subjects including the use of dietary supplements. Their role in the sale of and advice regarding natural health and drug alternatives
has never been more relevant.
The recent National Health Service (NHS) Interim People Plan calls for the NHS to put all staff front and centre of the way it operates and identifies pharmacists
as a critical part of multidisciplinary teams, providing care across a wide range of increasingly complex patient needs.
Despite existing demand to counsel patients on a vast range of medicines, more and more consumers are looking to their pharmacist to support and enhance their
knowledge regarding the relevance of a growing range of supplementary nutrients now available.
Nutritional supplementation is increasingly becoming the consumer's first choice for 'drug free' treatment or natural prevention that provides a true sense of
taking control, which the prescription process often denies them.
Historically the immense benefits provided by the NHS have instilled a general abdication of our personal health control, leaving us to rely on the health service
to treat and cure as necessary.
As our NHS has become visibly over-stretched we begin to realise what the rest of the world has known for centuries - good health is based primarily upon nutritional
robustness. It may be stating the obvious but there is an excellent source of incremental revenue for the pharmacist who is willing to provide space to and advice
for nutritional supplements.
Being the popular form of ART, In-vitro fertilization is a treatment that stands out to combat the infertility challenges when all other treatments fail.
The Pharmacist' Defence Association (PDA) has welcomed the General Pharmaceutical Council (GPhC) and the Pharmaceutical Society of Northern Ireland (PSNI)'s
plan to ensure a more robust, fair and positive experience for trainees, provisionally registered and potential pharmacists who will be sitting the November 2022
assessment.
"Many candidates at the latest (June 2022) assessment experienced significant delays, technical issues, inadequate invigilation, and disturbances in test centres
around the UK as the newly appointed company BTL ran the high-stakes pharmacist examinations for the first time. The next online exam is due in November 2022 and the
PDA welcome proposed improvements to be introduced before that sitting," said the association.
For some, provisional registration was the accepted response from the GPhC, but for others, such as potential pharmacists who did not want the provisional role,
those unable to find a suitable provisional post, or some that did not meet the criteria for provisional registration, they found themselves in financial
difficulties through no fault of their own, having reasonably expected to have joined the register in the Summer.